• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 RUBELLA IGM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 RUBELLA IGM Back to Search Results
Model Number IMMULITE 2000 RUBELLA IGM
Device Problem Device Ingredient or Reagent Problem (2910)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/20/2017
Event Type  malfunction  
Manufacturer Narrative
Siemens healthcare diagnostics has confirmed the rubella igm reagent lots d236m, d238, 236m, 237, 238, 239, and 239l on the immulite 2000/immulite 2000 xpi systems and reagent lots 333, and 334 on the immulite/immulite 1000 systems exhibit increased imprecision on patient samples.Siemens internal investigation demonstrate that some patient samples exhibit higher percent coefficient of variation (%cv) than the precision performance published in the instructions for use (ifu) for this assay.Quality controls provided in the rubella igm kit may not detect the imprecision with patient results.An urgent field safety notice (ufsn) imc16-20.A.Ous was sent to ous customers and a urgent medical device recall (umdr) imc16-20.A.Us was sent to us customers in august of 2016.The ufsn and umdr state that customers are to discontinue and discard the kits lots affected, and to request a replacement lot.Siemens recommends transitioning to immulite/1000 rubella igm kit lot 0337 and above or to immulite 2000/2000 xpi rubella igm kit lot 240 and above.The customer had received the ufsn and was aware of the issue with reagent lot 239.The customer was able to continue testing using a new reagent lot provided by siemens.
 
Event Description
The customer obtained discordant, false reactive rubella igm results on patient samples an immulite 2000 xpi instrument, when using reagent lot 239.It is unknown if the discordant results were reported to the physician(s).It is unknown if the samples were repeated and if the repeat results were reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant, false reactive rubella igm results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 RUBELLA IGM
Type of Device
IMMULITE 2000 RUBELLA IGM
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
registration #: 3002806944
glyn rhonwy
llanberis, gwynedd, LL55 4EL
UK  LL55 4EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
registration #: 3002806944
glyn rhonwy
llanberis, gwynedd, LL55 4EL
UK   LL55 4EL
Manufacturer Contact
aarti aziz
511 benedict avenue
tarrytown, NY 10591
9145242683
MDR Report Key6312264
MDR Text Key66879442
Report Number2432235-2017-00109
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
Reporter Country CodeMP
PMA/PMN Number
K012077
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Remedial Action Recall
Type of Report Initial
Report Date 02/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberIMMULITE 2000 RUBELLA IGM
Device Lot Number239
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/20/2017
Initial Date FDA Received02/08/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2432235-08/25/2016-002-R
Patient Sequence Number1
-
-